» Articles » PMID: 26264937

Quality of Life and Acquired Organ Damage Are Intimately Related to Activity Limitations in Patients with Systemic Lupus Erythematosus

Overview
Publisher Biomed Central
Specialties Orthopedics
Physiology
Date 2015 Aug 13
PMID 26264937
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Systemic lupus erythematosus (SLE) is an autoimmune multi-organ disease, characterized by episodes of disease flares and remissions over time, which may restrain affected patients' ability to perform daily activities. The purpose of the present study was to characterize variation in activity limitations among well-defined SLE patients, and to describe disease phenotypes, acquired organ damage and their relations to activity limitation and self-reported health, respectively.

Methods: The disease phenotypes were organized into 4 different clinical groups and logistic regression analyses were used to identify how an elevated health assessment questionnaire (HAQ) score was related to disease variables such as phenotypes, disease activity and damage accrual. Correlation and multiple linear regression analyses were used to examine the association between each group of variables - background variables, disease variables and self-reported measurements - and the degree of elevated HAQ.

Results: We found a higher proportion of activity limitation in patients with skin and joint involvement compared to others. The presence of activity limitation, as detected by the HAQ instrument, was significantly associated with quality of life (EuroQol-5D) and accrual of organ damage using the Systemic Lupus International Collaborative Clinics/ACR damage index.

Conclusions: The findings highlight the differing requirements of the multi-professional rehabilitation interventions for the various SLE phenotypes in order to optimize the clinical care of the patients.

Citing Articles

Patient-reported outcomes and healthcare resource utilization in systemic lupus erythematosus: impact of disease activity.

Touma Z, Costenbader K, Hoskin B, Atkinson C, Bell D, Pike J BMC Rheumatol. 2024; 8(1):22.

PMID: 38840229 PMC: 11151490. DOI: 10.1186/s41927-023-00355-6.


The prevalence of neutropenia and association with infections in patients with systemic lupus erythematosus: a Swedish single-center study conducted over 14 years.

Saleh M, Sjowall J, Bendtsen M, Sjowall C Rheumatol Int. 2024; 44(5):839-849.

PMID: 38502234 PMC: 10980633. DOI: 10.1007/s00296-024-05566-9.


Obesity and tobacco smoking are independently associated with poor patient-reported outcomes in SLE: a cross-sectional study.

Gomez A, Parodis I, Sjowall C Rheumatol Int. 2024; 44(5):851-861.

PMID: 38451301 PMC: 10980611. DOI: 10.1007/s00296-024-05546-z.


Lupus Low Disease Activity State and organ damage in relation to quality of life in systemic lupus erythematosus: a cohort study with up to 11 years of follow-up.

Parodis I, Haugli-Stephens T, Stephens T, Dominicus A, Eek D, Sjowall C Rheumatology (Oxford). 2024; 64(2):639-647.

PMID: 38402496 PMC: 11781577. DOI: 10.1093/rheumatology/keae120.


Development of a Conceptual Model to Understand Disease Burden in Patients With Systemic Lupus Erythematosus and Organ Damage.

Broderick L, Chen W, Levy R, Mitchell Foster A, Umanzor Figueroa C, Gairy K J Health Econ Outcomes Res. 2023; 10(2):30-38.

PMID: 37605768 PMC: 10440069. DOI: 10.36469/001c.82228.


References
1.
Ighe A, Dahlstrom O, Skogh T, Sjowall C . Application of the 2012 Systemic Lupus International Collaborating Clinics classification criteria to patients in a regional Swedish systemic lupus erythematosus register. Arthritis Res Ther. 2015; 17:3. PMC: 4318183. DOI: 10.1186/s13075-015-0521-9. View

2.
Enocsson H, Sjowall C, Wirestam L, Dahle C, Kastbom A, Ronnelid J . Four Anti-dsDNA Antibody Assays in Relation to Systemic Lupus Erythematosus Disease Specificity and Activity. J Rheumatol. 2015; 42(5):817-25. DOI: 10.3899/jrheum.140677. View

3.
Jonsen A, Bengtsson A, Hjalte F, Petersson I, Willim M, Nived O . Total cost and cost predictors in systemic lupus erythematosus - 8-years follow-up of a Swedish inception cohort. Lupus. 2015; 24(12):1248-56. DOI: 10.1177/0961203315584812. View

4.
Husted J, Gladman D, Farewell V, Cook R . Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis. Arthritis Rheum. 2001; 45(2):151-8. DOI: 10.1002/1529-0131(200104)45:2<151::AID-ANR168>3.0.CO;2-T. View

5.
Clarke A, St-Pierre Y, Joseph L, Penrod J, Sibley J, Haga M . Radiographic damage in rheumatoid arthritis correlates with functional disability but not direct medical costs. J Rheumatol. 2001; 28(11):2416-24. View